Advertisement
Screener

RELMADA THERAPEUTICS, INC. (RLMD) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

RELMADA THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where RELMADA THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-06-30: from running the business, $45.99M went out.
  • Fiscal year ended 2026-06-30: from investing, $187.82M went out.
  • Fiscal year ended 2026-06-30: from financing, $243.79M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$45.99M*-$187.82M*$243.79M*
2025-12-31-$45.79M-$48.14M$93.64M-$360.49K
2025-06-30-$49.92M*$49.53M*
2024-12-31-$51.76M$51.56M$246.75K-$234.54K
2024-06-30-$48.18M*$35.67M*
2023-12-31-$51.66M$50.45M-$1.30M
2023-06-30-$92.52M*$68.75M*
2022-12-31-$103.80M$19.73M$42.73M$2.29M*-$39.05M
2022-06-30-$99.63M*-$73.84M*$203.91M*$2.15M*
2021-12-31-$91.87M-$54.12M$184.64M$3.30M*$41.95M
2021-06-30-$52.73M*$15.08M*$722.14K*$27.77M*
2020-12-31-$27.81M-$34.45M$19.79M$8.68M*-$33.78M
2020-06-30-$14.79M*$139.54M*
2019-12-31-$12.09M-$80.16M$30.50M*$95.61M*$33.85M*
2019-06-30-$10.50M$17.84M$6.98M
2018-12-31-$8.71M*$5.21M*-$3.51M*
2018-06-30-$6.00M-$12.39K$6.54M*$528.43K
2017-12-31-$4.98M*-$25.02K*$6.23M*$1.23M*
2017-06-30-$6.47M-$49.69K-$6.79M
2016-12-31-$10.05M*-$113.41K*-$10.41M*
2016-06-30-$13.14M-$562.26K-$13.97M
2015-12-31-$15.61M*-$482.26K*
2015-06-30-$16.23M-$23.33K$13.16M*-$3.09M
2014-12-31-$9.47M*-$20.84K*$37.39M*
2013-12-31-$2.24M-$8.87K$4.00M*
2013-08-31-$11.86K-$1.80K$20.00K
2012-12-31-$1.58M$3.33M*
2012-08-31-$7.57K$13.50K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$9.61M*$17.59M*-$6.46M*-$159.90M*
2026-03-31-$15.07M-$135.23M-$3.36M$160.00M$6.28M
2025-12-31-$14.60M*-$76.93M*$93.64M*
2025-09-30-$6.72M*$6.75M*
2025-06-30-$6.40M*$6.68M*
2025-03-31-$18.07M$15.36M-$2.71M
2024-12-31-$8.80M*$11.35M*$0.00*
2024-09-30-$16.66M*$16.14M*$0.00*
2024-06-30-$13.26M*$14.01M*$0.00*
2024-03-31-$13.04M$10.06M$246.75K-$2.76M
2023-12-31-$10.25M*$7.74M*
2023-09-30-$11.63M*$3.86M*
2023-06-30-$13.27M*-$1.15M*
2023-03-31-$16.51M$40.00M$23.50M
2022-12-31-$35.88M*-$1.66M*$0.00*
2022-09-30-$26.86M*$31.56M*$0.00*$569.09K*
2022-06-30-$21.63M*-$140.52K*$13.15M*$948.09K*
2022-03-31-$19.43M-$10.03M$29.58M$490.94K
2021-12-31-$37.66M*-$91.18M*$161.23M*$610.10K*
2021-09-30-$20.92M*$27.51M*-$42.01K*
2021-06-30-$17.21M*-$5.91M*$49.50K*$23.94M*
2021-03-31-$16.09M$15.47M$467.77K$1.46M*$1.31M
2020-12-31-$6.93M*$935.28K*-$24.95K*$969.11K*
2020-09-30-$12.50M*$4.59M*-$38.42K*$1.67M*
2020-06-30-$4.95M*-$16.34M*$457.62K*$22.43M*
2020-03-31-$3.42M-$23.63M$73.02K$2.93M*-$24.05M
2019-12-31-$3.88M*$17.01M*$95.46M*$28.43M*
2019-09-30-$2.53M$825.75K-$1.37M
2019-06-30-$3.67M*$11.90M*-$1.07M*$7.16M*
2019-03-31-$2.01M$764.46K*$874.57K*-$372.90K
2018-12-31-$3.15M*$4.69M*$1.54M*
2018-09-30-$1.67M-$1.35M
2018-06-30-$2.27M*-$9.80K*-$2.02M*
2018-03-31-$1.63M*$0.00*-$1.68M*
2017-12-31-$1.13M*$0.00*$2.39M*$1.25M*
2017-09-30-$979.05K-$2.59K$3.96M*$2.97M
2017-06-30-$1.02M*-$2.20K*-$1.05M*
2017-03-31-$1.86M*-$20.23K*-$1.96M*
2016-12-31-$1.45M*-$2.43K*-$1.51M*
2016-09-30-$2.14M-$24.83K-$2.28M
2016-06-30-$2.83M*-$23.04K*-$2.85M*
2016-03-31-$3.63M*-$63.11K*-$3.78M*
2015-12-31-$3.48M*-$474.80K*-$4.04M*
2015-09-30-$3.22M-$1.31K-$3.30M
2015-06-30-$4.49M*-$3.87K*
2015-03-31-$4.43M*-$2.29K*
2014-12-31-$4.98M*-$6.50K*$9.02M*
2014-09-30-$2.32M-$10.67K$4.16M*
2014-06-30-$1.15M*-$3.02K*$24.26M*
2014-03-31-$1.02M-$649.00
2014-02-28-$3.54K*$0.00*$0.00*
2013-12-31-$420.58K*-$8.11K*
2013-11-30-$9.12K$0.00*$0.00*
2013-09-30-$408.70K-$762.00$2.80M*
2013-08-31-$5.37K*$0.00*$20.00K*
2013-05-31-$5.04K*$0.00*
2013-03-31-$399.88K
2013-02-28-$2.94K*
2012-11-30$1.50K
2012-08-31-$3.34K*$0.00*
2012-05-31-$1.99K*$9.50K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63